{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:01:07Z","timestamp":1778547667338,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gain-of-function mutations in <jats:italic>STING1<\/jats:italic> (also known as TMEM173) which result in constitutive activation of STING, have been reported to cause STING-associated vasculopathy with onset in infancy (SAVI). Although a wider spectrum of associated manifestations and perturbations in disease onset have been observed since its description, the genotype-phenotype correlations are not definite, and there is no established treatment protocol for SAVI.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Herein, we report a kindred, heterozygous STING mutation (p.V155M) in which the 2-year-old proband suffered from severe interstitial lung disease (ILD) while her father was initially misdiagnosed with connective tissue disease associated with ILD at an adult age. Baricitinib was initiated after the diagnosis of SAVI in the proband combined with steroids, and during the 14-month follow-up, the respiratory symptoms were improved. However, as the improvement of laboratory indicators was limited, especially in autoimmune indices, and the lung CT images remained unaltered, it seems that JAK1\/2 inhibition was unsatisfactory in completely controlling the inflammation of the disease in our study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Baricitinib was shown to elicit some effect on the ILD but failed to control the inflammation of the disease completely. Further exploration of JAK inhibitors or other therapeutic strategies are needed to more optimally treat this inflammatory disease.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12969-023-00916-6","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T09:02:17Z","timestamp":1698310937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Case report: JAK1\/2 inhibition with baricitinib in the treatment of STING-associated vasculopathy with onset in infancy"],"prefix":"10.1186","volume":"21","author":[{"given":"Jianqiang","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4930-9493","authenticated-orcid":false,"given":"Meiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"issue":"6","key":"916_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1312625","volume":"371","author":"Y Liu","year":"2014","unstructured":"Liu Y, Jesus AA, Marrero B, Yang D, Ramsey SE, Sanchez GAM, et al. Activated STING in a vascular and pulmonary syndrome. N Engl J Med. 2014;371(6):507\u201318. https:\/\/doi.org\/10.1056\/NEJMoa1312625.","journal-title":"N Engl J Med"},{"key":"916_CR2","doi-asserted-by":"publisher","first-page":"577918","DOI":"10.3389\/fped.2020.577918","volume":"8","author":"Y Dai","year":"2020","unstructured":"Dai Y, Liu X, Zhao Z, He J, Yin Q. Stimulator of Interferon genes-Associated Vasculopathy with Onset in Infancy: a systematic review of Case Reports. Front Pediatr. 2020;8:577918. https:\/\/doi.org\/10.3389\/fped.2020.577918.","journal-title":"Front Pediatr"},{"issue":"7","key":"916_CR3","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1172\/jci98814","volume":"128","author":"GAM Sanchez","year":"2018","unstructured":"Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, et al. JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. J Clin Invest. 2018;128(7):3041\u201352. https:\/\/doi.org\/10.1172\/jci98814.","journal-title":"J Clin Invest"},{"key":"916_CR4","doi-asserted-by":"publisher","unstructured":"Skopelja-Gardner S, An J, Elkon KB. Role of the cGAS-STING pathway in systemic and organ-specific Diseases. 2022;18(9):558\u201372. https:\/\/doi.org\/10.1038\/s41581-022-00589-6.","DOI":"10.1038\/s41581-022-00589-6"},{"key":"916_CR5","doi-asserted-by":"publisher","unstructured":"Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS-STING pathway as a therapeutic target in inflammatory Diseases. 2021;21(9):548\u201369. https:\/\/doi.org\/10.1038\/s41577-021-00524-z.","DOI":"10.1038\/s41577-021-00524-z"},{"key":"916_CR6","doi-asserted-by":"publisher","unstructured":"David C, Fr\u00e9mond ML. Lung inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI). 2022;11(3). https:\/\/doi.org\/10.3390\/cells11030318.","DOI":"10.3390\/cells11030318"},{"issue":"2","key":"916_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jaip.2020.11.007","volume":"9","author":"ML Fr\u00e9mond","year":"2021","unstructured":"Fr\u00e9mond ML, Hadchouel A, Berteloot L, Melki I, Bresson V, Barnabei L, et al. Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) among 21 patients. J Allergy Clin Immunol Pract. 2021;9(2):803\u201318e11. https:\/\/doi.org\/10.1016\/j.jaip.2020.11.007.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"916_CR8","doi-asserted-by":"publisher","unstructured":"Tang X, Xu H, Zhou C, Peng Y, Liu H, Liu J et al. STING-Associated Vasculopathy with Onset in Infancy in three children with New Clinical aspect and unsatisfactory therapeutic responses to Tofacitinib. 2020;40(1):114\u201322. https:\/\/doi.org\/10.1007\/s10875-019-00690-9.","DOI":"10.1007\/s10875-019-00690-9"},{"issue":"3","key":"916_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10875-021-00974-z","volume":"41","author":"ML Fr\u00e9mond","year":"2021","unstructured":"Fr\u00e9mond ML, Crow YJ. STING-Mediated lung inflammation and Beyond. J Clin Immunol. 2021;41(3):501\u201314. https:\/\/doi.org\/10.1007\/s10875-021-00974-z.","journal-title":"J Clin Immunol"},{"key":"916_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01431-9","author":"C Ladoux","year":"2023","unstructured":"Ladoux C, Pasquet M, Crow YJ, Fr\u00e9mond ML, Roditis L. STING-Associated Vasculopathy with Onset in infancy (SAVI) presenting as massive intra alveolar Hemorrhage. J Clin Immunol. 2023. https:\/\/doi.org\/10.1007\/s10875-023-01431-9.","journal-title":"J Clin Immunol"},{"issue":"2","key":"916_CR11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.21037\/atm-20-6198","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang F, Zhang X. STING-associated vasculopathy with onset in infancy: a familial case series report and literature review. Ann Transl Med. 2021;9(2):176. https:\/\/doi.org\/10.21037\/atm-20-6198.","journal-title":"Ann Transl Med"},{"key":"916_CR12","doi-asserted-by":"publisher","first-page":"575219","DOI":"10.3389\/fimmu.2020.575219","volume":"11","author":"F Staels","year":"2020","unstructured":"Staels F, Betrains A, Doubel P, Willemsen M, Cleemput V, Vanderschueren S, et al. Adult-Onset ANCA-Associated Vasculitis in SAVI: extension of the phenotypic spectrum, Case Report and Review of the literature. Front Immunol. 2020;11:575219. https:\/\/doi.org\/10.3389\/fimmu.2020.575219.","journal-title":"Front Immunol"},{"key":"916_CR13","doi-asserted-by":"publisher","first-page":"825367","DOI":"10.3389\/fimmu.2022.825367","volume":"13","author":"W Li","year":"2022","unstructured":"Li W, Wang W, Wang W, Zhong L, Gou L, Wang C, et al. Janus Kinase Inhibitors in the treatment of type I interferonopathies: a Case Series from a single Center in China. Front Immunol. 2022;13:825367. https:\/\/doi.org\/10.3389\/fimmu.2022.825367.","journal-title":"Front Immunol"},{"issue":"7","key":"916_CR14","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.2169\/internalmedicine.5305-20","volume":"60","author":"T Nishida","year":"2021","unstructured":"Nishida T, Nakano K, Inoue Y, Narumi-Kishimoto Y, Kaname T, Akashi K, et al. Stimulator of Interferon genes-associated Vasculopathy with an onset in Infancy diagnosed after the development of atypical pulmonary lesions during treatment as juvenile idiopathic arthritis. Intern Med. 2021;60(7):1109\u201314. https:\/\/doi.org\/10.2169\/internalmedicine.5305-20.","journal-title":"Intern Med"},{"issue":"6","key":"916_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/humu.20720","volume":"29","author":"F Milhavet","year":"2008","unstructured":"Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I, et al. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat. 2008;29(6):803\u20138. https:\/\/doi.org\/10.1002\/humu.20720.","journal-title":"Hum Mutat"},{"key":"916_CR16","doi-asserted-by":"publisher","first-page":"1029423","DOI":"10.3389\/fimmu.2022.1029423","volume":"13","author":"R Wan","year":"2022","unstructured":"Wan R, F\u00e4nder J, Zakaraia I, Lee-Kirsch MA, Wolf C, Lucas N, et al. Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: four novel cases and analysis of previously reported cases. Front Immunol. 2022;13:1029423. https:\/\/doi.org\/10.3389\/fimmu.2022.1029423.","journal-title":"Front Immunol"},{"key":"916_CR17","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3389\/fped.2020.00543","volume":"8","author":"J Li","year":"2020","unstructured":"Li J, An S, Du Z. Familial interstitial lung Disease caused by mutation of the STING1 gene. Front Pediatr. 2020;8:543. https:\/\/doi.org\/10.3389\/fped.2020.00543.","journal-title":"Front Pediatr"},{"key":"916_CR18","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.3389\/fimmu.2018.01535","volume":"9","author":"RG Saldanha","year":"2018","unstructured":"Saldanha RG, Balka KR, Davidson S, Wainstein BK, Wong M, Macintosh R, et al. A mutation outside the Dimerization Domain Causing Atypical STING-Associated Vasculopathy with Onset in Infancy. Front Immunol. 2018;9:1535. https:\/\/doi.org\/10.3389\/fimmu.2018.01535.","journal-title":"Front Immunol"},{"issue":"16","key":"916_CR19","doi-asserted-by":"publisher","first-page":"7941","DOI":"10.1073\/pnas.1818281116","volume":"116","author":"M Motwani","year":"2019","unstructured":"Motwani M, Pawaria S, Bernier J, Moses S, Henry K, Fang T, et al. Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models. Proc Natl Acad Sci U S A. 2019;116(16):7941\u201350. https:\/\/doi.org\/10.1073\/pnas.1818281116.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"916_CR20","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.jaci.2016.07.015","volume":"138","author":"ML Fr\u00e9mond","year":"2016","unstructured":"Fr\u00e9mond ML, Rodero MP, Jeremiah N, Belot A, Jeziorski E, Duffy D, et al. Efficacy of the Janus kinase 1\/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173-activating mutations in 3 children. J Allergy Clin Immunol. 2016;138(6):1752\u20135. https:\/\/doi.org\/10.1016\/j.jaci.2016.07.015.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"916_CR21","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s10875-019-00645-0","volume":"39","author":"S Volpi","year":"2019","unstructured":"Volpi S, Insalaco A, Caorsi R, Santori E, Messia V, Sacco O, et al. Efficacy and adverse events during Janus kinase inhibitor treatment of SAVI Syndrome. J Clin Immunol. 2019;39(5):476\u201385. https:\/\/doi.org\/10.1007\/s10875-019-00645-0.","journal-title":"J Clin Immunol"},{"issue":"2","key":"916_CR22","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/cpt.936","volume":"104","author":"H Kim","year":"2018","unstructured":"Kim H, Brooks KM, Tang CC, Wakim P, Blake M, Brooks SR, et al. Pharmacokinetics, Pharmacodynamics, and proposed dosing of the oral JAK1 and JAK2 inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI patients. Clin Pharmacol Ther. 2018;104(2):364\u201373. https:\/\/doi.org\/10.1002\/cpt.936.","journal-title":"Clin Pharmacol Ther"},{"key":"916_CR23","doi-asserted-by":"publisher","unstructured":"Cetin Gedik K, Lamot L, Romano M, Demirkaya E, Piskin D, Torreggiani S et al. The 2021 European Alliance of Associations for Rheumatology\/American College of Rheumatology Points to consider for diagnosis and management of Autoinflammatory Type I interferonopathies: CANDLE\/PRAAS, SAVI, and AGS. 2022;74(5):735\u201351. https:\/\/doi.org\/10.1002\/art.42087.","DOI":"10.1002\/art.42087"},{"issue":"2","key":"916_CR24","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1136\/annrheumdis-2016-209841","volume":"76","author":"N K\u00f6nig","year":"2017","unstructured":"K\u00f6nig N, Fiehn C, Wolf C, Schuster M, Cura Costa E, T\u00fcngler V, et al. Familial chilblain lupus due to a gain-of-function mutation in STING. Ann Rheum Dis. 2017;76(2):468\u201372. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209841.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"916_CR25","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.jaci.2016.10.030","volume":"139","author":"J Seo","year":"2017","unstructured":"Seo J, Kang JA, Suh DI, Park EB, Lee CR, Choi SA, et al. Tofacitinib relieves symptoms of stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173. J Allergy Clin Immunol. 2017;139(4):1396\u20139e12. https:\/\/doi.org\/10.1016\/j.jaci.2016.10.030.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"916_CR26","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jaci.2020.06.032","volume":"146","author":"B Lin","year":"2020","unstructured":"Lin B, Berard R, Al Rasheed A, Aladba B, Kranzusch PJ, Henderlight M, et al. A novel STING1 variant causes a recessive form of STING-associated vasculopathy with onset in infancy (SAVI). J Allergy Clin Immunol. 2020;146(5):1204\u20138e6. https:\/\/doi.org\/10.1016\/j.jaci.2020.06.032.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"916_CR27","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.celrep.2018.03.115","volume":"23","author":"H Konno","year":"2018","unstructured":"Konno H, Chinn IK, Hong D, Orange JS, Lupski JR, Mendoza A, et al. Pro-inflammation Associated with a gain-of-function mutation (R284S) in the Innate Immune Sensor STING. Cell Rep. 2018;23(4):1112\u201323. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.115.","journal-title":"Cell Rep"},{"issue":"1","key":"916_CR28","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jaad.2015.10.007","volume":"74","author":"J Chia","year":"2016","unstructured":"Chia J, Eroglu FK, \u00d6zen S, Orhan D, Montealegre-Sanchez G, de Jesus AA, et al. Failure to thrive, interstitial lung Disease, and Progressive digital necrosis with onset in infancy. J Am Acad Dermatol. 2016;74(1):186\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2015.10.007.","journal-title":"J Am Acad Dermatol"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00916-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-023-00916-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-023-00916-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T09:04:02Z","timestamp":1698311042000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-023-00916-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["916"],"URL":"https:\/\/doi.org\/10.1186\/s12969-023-00916-6","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]},"assertion":[{"value":"26 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was not applicable. Informed consent was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from the patient\u2019s guardian. Written informed consent was obtained from the legal guardians as the patient was aged\u2009<\u200916 years. This was applicable for all potentially identifiable information contained within the manuscript file and is available for review by the editor of the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"131"}}